CPC Cell & Gene Tech Expo April 2025: Cell Therapy

The rapid evolution of cell and gene therapy (CGT) has driven demand for advanced sterile connector technology that ensures aseptic fluid transfer while maintaining process integrity, scalability, and regulatory compliance. Innovations in single-use sterile connectors are transforming CGT bioprocessing by enhancing fluid handling efficiency, reducing contamination risks, and enabling seamless integration into closed systems.

In this presentation, we explore recent advancements in single-use connector technology and the use in CGT process manufacturing. Additionally, we examine the role of these innovations for streamlining workflows, improving process reliability, and driving cost efficiencies. As CGT moves toward commercialization, optimizing sterile connectivity will be critical to overcoming key manufacturing challenges and driving the next generation of advanced therapies.